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Abstract We immunohistochemically examined the distribution 
of glucokinase in rat pancreatic islets. Glucokinase immuno-
reactivity under light microscopy was detected in the cytoplasm 
of somatostatin cells as well as in that of insulin cells. No specific 
immunoreactivity was detected in glucagon and pancreatic 
polypeptide cells. In somatostatin cells, glucokinase immuno-
reactivity was located by electron microscopy exclusively within 
secretory granules. 
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1. Introduction 
Glucokinase (ATP:D-hexose 6-phosphotransferase, EC 
2.7.1.1) is often called hexokinase IV and catalyzes the phos-
phorylation of glucose. It is distinguished from other hexoki-
nase isozymes (types I—III) by its low affinity for glucose and 
lack of inhibition by glucose 6-phosphate [1]. This enzyme has 
been identified only in pancreatic islet cells, hepatocytes, and 
some neuroendocrine cells [2]. Expression of glucokinase in 
pancreatic B-cells [3,4] and hepatocytes [1] is believed to be 
of major physiological importance for the maintenance of 
glucose homeostasis. It has been established that glucokinase 
in B-cells of pancreatic islets acts as a glucose sensor for 
glucose-induced insulin secretion [5,6]. However, the distribu-
tion of the enzyme in pancreatic islets has not yet been fully 
examined. 
Similarities between the effects of glucose on somatostatin 
and insulin secretion were shown with respect to various 
points, i.e. sigmoidal dose-response relationship [7], glucose-
anomeric preference [8], and inhibition by mannoheptulose, 
an inhibitor of glucokinase [8]. Both the sigmoidal dose-re-
sponse curve and the a-anomeric preference in glucose-in-
duced insulin secretion were explained by the kinetic proper-
ties of the glucokinase reaction [6,9,10]. Therefore, it is to be 
expected that glucokinase exists in D-cells as well as in B-cells 
and serves as a glucose sensor in the former cells. 
The aim of the present study was to examine the glucoki-
nase distribution in pancreatic islet cells and to obtain more 
information on the physiological function of glucokinase in 
this organ. This is the first report on the ultrastructural ex-
amination of glucokinase distribution. 
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2. Materials and methods 
2.1. Antibody 
The antibody against glucokinase was generated in a rabbit that 
had been immunized with an 11-amino acid peptide with the sequence 
(NH2)-YACKKACMLAQ-(COOH). For preparation of the anti-pep-
tide antibody, 100 |ig of the synthetic peptide coupled to keyhole 
limpet hemocyanin in Freund's complete adjuvant was injected sub-
cutaneously into a New Zealand white rabbit, and booster injections 
were given once a month for 4 months. 
2.2. Affinity purification of the anti-peptide antibody 
One milliliter of antiserum against anti-peptide was loaded onto a 
1-ml HiTrap protein A column (Pharmacia, Sweden). After the col-
umn had been washed with 0.1 M Tris-HCl buffer (pH 8.0), the 
bound IgG was eluted from the column with 0.1 M glycine-HCl buffer 
(pH 2.8). Fractions (3 ml each) were collected into tubes containing 
0.5 ml of 1 M Tris-HCl buffer (pH 8.0). The IgG was further purified 
by sequential adsorption to and elution from rat liver glucokinase 
immobilized onto polyivinylidene difluoride) membranes as described 
previously [11]. 
2.3. Immunohistochemistry 
2.3.1. Fixation. Male Wistar rats weighing 180-220 g were used. 
They had free access to water and food (MM-3; Funabashi Farm, 
Japan). The animals were anesthetized by an intraperitoneal injection 
of sodium pentobarbital (50 mg/kg body weight) and perfused 
through the left ventricle with 0.15 M phosphate-buffered saline 
(PBS) (pH 7.3) and successively with 4% paraformaldehyde in 0.1 
M phosphate buffer (pH 7.3). The pancreas was then removed and 
minced into small tissue blocks. The blocks were further immersed in 
the same fixative for 12 h at room temperature, dehydrated through a 
graded ethanol series and propylene oxide, and embedded in Epon 
812 [12]. 
2.3.2. Light-microscopic immunohistochemistry. Semithin sections 
were cut at a thickness of 0.5 urn on an LKB microtome (Ultrotome 
V), and mounted on glass slides by heating (80°C). Resin was re-
moved from the sections with sodium methoxide according to the 
method of Mayor et al. [13] immediately before immunostaining. 
The sections were incubated consecutively with affinity-purified anti-
peptide IgG (diluted 1:10 in 5% normal goat serum) overnight at 4°C, 
with biotin-labeled goat serum against rabbit IgG (Seikagaku, Japan) 
for 1 h at room temperature, and with streptavidin-peroxidase (Sei-
kagaku, Japan) for 30 min at room temperature. Each incubation was 
followed by three washes with PBS. Finally, the sections were soaked 
for 15 min at room temperature in 0.05 M Tris-HCl buffer (pH 7.6) 
containing 0.0125% 3,3'-diaminobenzidine-4HCl and 0.01% (w/v) 
H2O2, washed with distilled water, dehydrated, mounted with Entel-
lan New (Merck, Germany), and examined by light microscopy. 
2.3.3. Electron-microscopic immunocytochemistry. A post-embed-
ding, immunogold-staining method was adopted. Ultrathin sections 
were cut on an LKB microtome and mounted on non-coated nickel 
grids. After having been etched with a saturated aqueous solution of 
sodium metaperiodate for 1 h, the grids with sections were incubated 
overnight at 4°C with anti-peptide antibody (diluted 1:10). The grids 
were then incubated with anti-rabbit IgG coupled to 5-nm gold par-
ticles (AuroProbe EM GAR G5, Amersham, UK). After completion 
of the immunostaining procedures, the grids were treated with a sil-
ver-enhancement reagent (IntenSE M Kit, Amersham, UK) to in-
crease the size of the gold marker. The specimens thus prepared 
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Fig. 1. Two series (A-C and D-F) of serial semithin sections showing immunohistochemical distribution of glucokinase (B, E), insulin (A), glu-
cagon (C), somatostatin (D), and pancreatic polypeptide (F) in pancreatic islets. Arrow, double arrow, arrowhead, and double arrowhead indi-
cate insulin-, glucagon-, somatostatin-, and pancreatic polypeptide-containing cells, respectively. Bar = 25 |xm. 
were stained with uranyl acetate and examined with a JEOL 1200EX 
transmission electron microscope under an accelerating voltage of 80 
kV. 
2.4. Specificity controls 
In control experiments, semithin sections were incubated with anti-
peptide antibody that had been absorbed with an excess of purified rat 
liver glucokinase, with non-immune rabbit IgG, or with pre-immune 
rabbit IgG, followed by consecutive incubation with biotin-labeled 
goat serum against rabbit IgG and streptavidin-peroxidase. Some sec-
tions were directly incubated with the second antibody without any 
preceding incubation with anti-peptide antibody. 
3. Results and discussion 
Clear and positive glucokinase immunoreactivity was ob-
served in pancreatic islets by light microscopy (Fig. 1B,E). 
We established the specificity of immunostaining for glucoki-
nase as follows: (i) no staining was observed when non-im-
mune or pre-immune IgG was used instead of the anti-peptide 
antibody, (ii) no staining was observed when sections were 
incubated with the second antibody without preceding incu-
bation with the anti-peptide antibody, (iii) immunoabsorption 
of the anti-peptide antibody with purified rat liver glucokinase 
completely prevented immunostaining of glucokinase, and (iv) 
no staining was seen in the sections of kidney and skeletal 
muscle of rats incubated with anti-peptide antibody (data 
not shown). 
Glucokinase immunoreactivity was restricted to the islets of 
Langerhans. Analysis of consecutive sections immunostained 
for insulin, glucagon, somatostatin, and pancreatic poly-
peptide indicated that glucokinase was present in B-cells 
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Fig. 2. Ultrastructural distribution of glucokinase in D-cells exam-
ined by the immunogold method. The location of glucokinase im-
munoreactivity within somatostatin-secretory granules is shown at 
low (A) and high (B) magnification. Original magnification: (A) 
X10000; (B) X 76000. 
(Fig. 1A,B) and D-cells (Fig. 1D,E), but not in A-cells (Fig. 
1B,C) or PP-cells (Fig. 1E,F). In both B- and D-cells, gluco-
kinase immunoreactivity was present predominantly in the 
cytoplasm. In addition, it should be noted that the extent of 
glucokinase immunoreactivity in B- and D-cells was positively 
correlated with that of immunoreactivity of insulin and soma-
tostatin, respectively, indicating that the majority of glucoki-
nase in pancreatic islets is located in the cytoplasm of B- and 
D-cells. The absence of glucokinase immunoreactivity in A-
cells was contradictory to a previous paper [14] reporting that 
rat pancreatic A-cells express glucokinase mRNA and protein. 
One of the possible explanations for this contradiction is that 
the amount of glucokinase in A-cells is too low to be detected 
by our immunohistochemical method. 
At the electron microscopic level, glucokinase immunoreac-
tivity in D-cells was present exclusively within somatostatin-
secretory granules (Fig. 2). Glucokinase immunoreactivity as 
assessed by light microscopy was somewhat higher in D-cells 
than in B-cells (Fig. 1), suggesting that the intracellular con-
centration of the enzyme is higher in the former cells than in 
the latter ones. This might be the reason for the clear staining 
of glucokinase in D-cells and for the subtle staining in B-cells 
observable by electron microscopy. 
It is not yet known whether the glycolytic pathway operates 
in somatostatin-secretory granules. If it is the case, it is likely 
that glucokinase in the granules acts as a glucose sensor as 
demonstrated in B-cells. If the enzymes of the glycolytic path-
way are not present all together in the granules, an unknown 
function of glucokinase should be explored. Very recently, 
nitric-oxide synthase was reported to be present in the secre-
tory granules of pancreatic A- and D-cells [15]. Some inves-
tigators also reported that a type II isoform of adenylate 
cyclase was located in the secretory granules of pancreatic 
A- and B-cells [16]. The function of the two enzymes in the 
secretory granules has not yet been defined. Elucidation of the 
physiological meaning of the presence of these enzymes in-
cluding glucokinase should shed light on the mechanism of 
hormone release from the pancreatic islet. 
Noma et al. [17] indicated that the stimulation of islet B-
cells by glucose results in the translocation of glucokinase 
towards the periphery of the cell. Furthermore, recent studies 
from our laboratory have shown that in rat hepatocytes glu-
cokinase is located predominantly in the nucleus under meta-
bolically static conditions and that metabolic conditions lead-
ing to an increase in glucose metabolism cause translocation 
of the enzyme from the nucleus to the cytoplasm [11,18-22]. 
We also suggested that the translocation of glucokinase be-
tween the nucleus and the cytoplasm plays a major role in the 
regulation of hepatic glucose metabolism [19-22]. It remains 
to be investigated whether glucokinase in D-cells is translo-
cated between the granule and the cytoplasm in response to 
changes in blood glucose concentration. 
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